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Abstract
Background: Pulse wave velocity is an important measure of cardiovascular risk, and can be measured by several
different techniques. We compared age-related changes in pulse wave velocity derived from carotid and femoral
artery waveforms using the Vicorder device and descending thoracic aorta time velocity curves using phase contrast
magnetic resonance imaging (MRI) in a group of normal healthy volunteers, without cardiovascular disease, aged
between 20 and 79 years.
Methods: Eighty subjects underwent same-day measurements of Vicorder and MRI pulse wave velocity measurements.
Results: Both Vicorder and MRI-based pulse wave velocity measurements were significantly increased with age
(R = 0.59 and 0.57 respectively, both P < 0.0001). Vicorder and MRI pulse wave velocities were also significantly
related to each other (R = 0.27, P < 0.05), and Bland Altman plots showed that on average Vicorder measurements were
1.6 m/s greater than MRI. In 5 % of cases, agreement between the values of the two techniques were above and
below 2 standard deviations, and these were at higher levels of pulse wave velocities. Multiple linear stepwise
regression analysis confirmed highly significant relationships of both techniques to age (both P < 0.0001), and
MRI was also significantly related to heart rate (P = 0.006) but Vicorder was not.
Conclusions: Both Vicorder and MRI perform similarly in detecting age-related changes in pulse wave velocity.
Thus, the choice of using one or the other will depend on other aspects of the investigation, such as the need
for portability favouring Vicorder, or need for additional cardiovascular imaging favouring MRI.
Trial registration: ClinicalTrials.Gov identifier NCT01504828
Keywords: Pulse wave velocity, Vicorder, Phase contrast magnetic resonance imaging, Ageing
Background
Arterial stiffness is an important determinant of cardio-
vascular risk, and measurement of pulse wave velocity is
the most accepted measure of arterial stiffness [1–3].
This can be non-invasively measured by Doppler [4] or
high fidelity pressure measuring devices to measure
pulse wave velocity [5]. A quite different approach is to
use phase contrast magnetic resonance imaging (MRI),
measuring velocity in two or more slices of the thoracic
aorta from flow waveforms [6, 7]. These inherently dif-
ferent techniques have distinct advantages and disad-
vantages. Measurements from pressure waveform
techniques are relatively easily done, do not require ex-
tensive training, are quick, and can be brought to the
patient. A disadvantage of the pressure techniques is
that the measurement of carotid to femoral length is
an external anatomical surface measure along the
course of the major blood vessels and so is prone to
error [8]. MRI requires significant expertise, highly
trained staff, and can only be done at specialised cen-
tres. Nevertheless, the measurement of length along
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the aorta between the two slices where flow is mea-
sured is very accurate. Furthermore, MR imaging can
be used to measure several aspects of cardiac and vas-
cular function – so if these are already being acquired
using MRI, the addition of MRI to measure vascular
stiffness is relatively straightforward with advanced 4D
phase contrast MRI [9].
The Vicorder device (Skidmore Medical, UK) is an in-
flatable cuff-based device that simultaneously measures
the upstroke of carotid and femoral pulsations to calcu-
late pulse wave velocity. It has shown good reproduci-
bility [10] even when used by subjects with limited
experience in using the device [11], and compares well
with invasive measures of central blood pressure [12],
and with measures of pulse wave velocity from the
SphygmoCor device [10]. The purpose of this study was
to compare measurements of pulse wave velocity using
MRI and the Vicorder device in a population of normal
subjects, without cardiovascular disease, but a wide
range of ages.
Methods
Subjects
This study was performed as part of a larger project of
ageing effects on cardiovascular function in normal
subjects without a cardiovascular diagnosis, hypertension
diabetes, or renal disease requiring dialysis (Cardiac Ener-
getics and Function in Normal Human Ageing, Clinical-
Trials.Gov identifier NCT01504828). Exclusion criteria
were as above and also known claustrophobia. To get a
consistent spread of ages we recruited subjects stratified
by age ranges from 20 to 79 years. These and other gen-
eral data are shown in Table 1. Informed consent was ob-
tained for all patients, and this study was approved by a
UK National Health Service Research Ethics Committee
(NRES Committee North East - Newcastle & North Tyne-
side 1, reference number 12/NE/0057). All subjects had
measurements of pulse wave velocity by the Vicorder de-
vice and Phase Contrast MRI on the same day within 2 h.
Vicorder pulse wave velocity and other haemodynamic
measurements
The Vicorder measurements were performed by trained
research nurses. Patients (non fasting) were laid on an a
couch in a quiet clinic room, with the head raised to ap-
proximately 300, so that the skin and muscles over the
carotid were relaxed though not too tense. Pulse wave
velocity was measured by a cuff placed over the right ca-
rotid and the right thigh. The length between the carotid
and femoral arteries was done by measuring the length
between the suprasternal notch and the mid-point of the
thigh cuff (Table 2). Measurements were taken until
pressure waveforms over the carotid and thigh area were
clear and reproducible. At a later date the lead investiga-
tor reviewed all tracings and if necessary selected only
those data with clear pressure waveform upstrokes. Add-
itional measurements with the Vicorder device were per-
formed with a cuff placed on the right upper arm. These
included oscillatory blood pressure measurement and
using a global transfer function, central aortic pressures
[13] and augmentation and augmentation index. Inter-
observer measurements of pulse wave velocity with these
methods (N = 32) were 7.8 ± 1.6 and 7.6 ± 1.6 m/s with
mean difference of 0.2 ± 0.8 m/s (linear regression r =
0.89), and intra-observer measurements (N = 3) of 6.1 ± 1.0
and 6.1 ± 0.9 m/s with mean difference of 0.03 ± 0.25 m/s.
Phase contrast MRI
Phase contrast MRI acquisitions were specifically designed
to acquire time-velocity curves at two slices locations (aor-
tic arch and descending aorta approximately 10 cm apart)
to estimate transit time (ΔT) as shown in Fig. 1. Subjects
were scanned using a Philips Achieva 3 Tesla scanner
and a six channel cardiac coil was employed for signal
reception. Phase contrast MRI data was acquired by
Table 1 Patient characteristics by age groups
Age groups (years):
20–29 30–39 40–49 50–59 60–69 70–79
N 15 14 14 14 12 11
Gender (male) 5 7 6 6 8 6
Height 172 ± 8.1 174 ± 9.1 176 ± 12.5 174 ± 8.5 171 ± 9.1 164 ± 11.4
Weight 77 ± 16.6 75 ± 12.8 78 ± 9.9 77 ± 17.1 74 ± 18.1 70 ± 16.5
Glucose 4.8 ± 0.4 4.8 ± 0.5 4.9 ± 0.3 5.0 ± 0.5 5.3 ± 0.6 4.9 ± 0.5
Cholesterol 4.6 ± 0.9 4.2 ± 0.6 4.8 ± 0.9 4.9 ± 0.7 4.8 ± 0.7 5.1 ± 1.0
Triglycerides 0.9 ± 0.5 0.8 ± 0.3 0.9 ± 0.4 0.9 ± 0.7 0.9 ± 0.4 1.0 ± 0.3
HDL 1.5 ± 0.4 1.7 ± 0.3 1.5 ± 0.5 1.8 ± 0.6 1.7 ± 0.5 1.6 ± 0.3
LDL 2.7 ± 0.8 2.3 ± 0.6 2.9 ± 0.7 2.7 ± 0.8 2.7 ± 0.6 3.0 ± 0.8
Height (cm), weight (kg), all lipids and glucose measured in mmol/L
HDL high density lipoprotein, LDL low density lipoprotein
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experienced radiographers using a high temporal reso-
lution sequence (repetition time / echo time / flip angle /
number of excitations / slice thickness = 5 ms/2.9 ms/100/
1/8 mm, SENSE factor 2, field of view 300 mm× 225 mm,
reconstructed voxel size 1.17 mm2, velocity encoding =
150 m/s, 44 phases, breath hold duration ~19 s) at both
slice locations which were the aortic arch (AAo) and the
descending (DAo) aorta (Fig. 1). Additional scout images
were acquired to facilitate positioning of the phase con-
trast MR acquisitions and to ensure that the slices were
positioned perpendicular to aorta at both locations. Q-
flow analysis package (Philips, Viewform) was employed
to extract time-velocity curves as shown in Fig. 1 and
to estimate precise distance (ΔX) between the two slice
locations. The time-velocity curves were then used to
determine transit time (ΔT) and compute MR pulse
wave velocity = ΔX/ΔT using an in house Matlab based
program. A reproducibility analysis of this technique
was performed in seven normal volunteers, repeating
scans at two sessions, and within each session perform-
ing the scanning twice. For session one the values were
4.9 ± 1.6 and 4.5 ± 1.6 m/s (mean difference 0.4 ± 0.9)
and session two 5.5 ± 1.6 and 5.2 ± 1.2 m/s (mean dif-
ference 0.3 ± 0.7).
Table 2 Pulse wave velocities and the arterial length measured by age group
Age groups (years):
20–29 30–39 40–49 50–59 60–69 70–79
Vicorder PWV 6.7 ± 0.9 6.9 ± 1.0 7.5 ± 1.2 8.0 ± 1.7 8.1 ± 1.2 9.5 ± 1.4
MRI PWV 4.5 ± 1.5 5.1 ± 0.8 6.5 ± 1.7 6.2 ± 1.6 6.8 ± 2.1 7.9 ± 1.5
Vicorder Length 63 ± 6 65 ± 6 64 ± 6 68 ± 7 67 ± 7 65 ± 9
MRI Length 10 ± 1 10 ± 2 10 ± 1 9.9 ± 8 10 ± 1 10 ± 2
PWV pulse wave velocity, m/sec, and lengths: cm
Fig. 1 Illustration of Vicorder and phase contrast MRI techniques. In panel a, examples of simultaneous Vicorder carotid and femoral arterial
waveforms are shown. Panel b shows the two slices of thoracic aorta (AAo – aortic arch, and DAo descending aorta) between which distance is
measured (ΔX), and in panel c phase contrast MRI flow images showing ΔT which is the time delay between of the initial upstroke in flow
between the two slices
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Data and statistical analysis
Data are expressed as mean ± standard deviation. Uni-
variate associations of both Vicorder and MRI were
tested with Pearson’s correlation, and multiple linear
stepwise regression models to test the role of multiple
parameters incorporating all the parameters from the Uni-
variate analysis. Stepwise criteria were: Probability-of-F-
to-enter < = 0.050, Probability-of-F-to-remove > = 0.100).
SPSS version 21 was used for all statistics. P < 0.05 was
considered significant.
Results
Ninety nine patients were recruited to the main research
study (between 16 and 18 subjects for each age decile
from 20 to 79 years). Nine patients were excluded from
this study because the Vicorder data was not adequate,
usually because the carotid waveform was unclear. Six of
these patients were over 50 years. Ten patients were ex-
cluded due to issues with the MR imaging. Three pa-
tients could not tolerate the MR scanning due to
claustrophobia so were withdrawn. Six patients had very
short transit times measured in the thoracic aorta (> 2
standard deviations from the mean). Review of these in-
dividual cases revealed that there were difficulties in po-
sitioning slices perpendicular to the aorta, particularly in
those with more curved aortic arches. Five out of seven
of these subjects were above 60 years of age. The
remaining 80 subjects are the subject of this analysis.
Comparison of Vicorder and MRI measures of pulse
wave velocity
Both techniques were significantly and similarly related
to age (Table 2 and Fig. 2, Vicorder R = 0.594, and MRI
R = 0.572), with R2 values in both accounting for be-
tween 35 and 33 % respectively of the variances in the
model (both P < 0.0001). Vicorder and MRI were also
significantly correlated (Fig. 3a, R = 0.271, 7 % of vari-
ance, P < 0.05). Bland Altman plot (Fig. 3b) showed that
in general the mean difference between the 2 measures
was 1.6 m/s greater for Vicorder. Also, particularly at
higher measurements of pulse wave velocity, there were
four individual cases that were greater than two standard
deviations greater or less than the mean difference.
Correlates of both measurements of pulse wave velocity
Hemodynamic data are presented by age group in
Table 3. Vicorder pulse wave velocity was significantly
related to all these hemodynamic variables. In general,
the extent of significant correlations with these mea-
surements were less with the MRI (Table 4), though
there were highly significant correlations with aortic
pulse pressure, augmentation and augmentation index.
Multivariate analysis was performed separately for
both techniques to compare how they related to other
physiological variables (Tables 5 and 6). For Vicorder,
age alone was significantly related to pulse wave vel-
ocity. For MRI age and heart rate were significantly re-
lated. In both cases the slope (Beta) against age was
similar (Vicorder 0.603 and MRI 0.632).
Discussion
This study shows that when comparing two very differ-
ent techniques for measuring pulse wave velocity that a)
there is a very similar and highly significant relationship
to age, b) there is a similar failure rate of approximately
10 % to obtain usable data in both techniques, c) that
these failures and higher variances from the mean differ-
ences are greater in older subjects and those with higher
values of pulse wave velocity.
Two different techniques
The Vicorder and MRI are fundamentally two different
techniques. The Vicorder measurements rely on pressure
waveforms whereas MRI is based on flow. The other
Fig. 2 Relationship of Vicorder to age (a) (y = 0.055x + 5.033, R2 = 0.353,
R = 0.594, P < 0.0001) and phase contrast MRI to age (b) (y = 0.067x +
2.859, R2 = 0.327, R = 0.572, P < 0.0001). PWV: pulse wave velocity
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major difference is the region from which the pulse wave
velocity is measured. The MRI is measured in a rela-
tively small segment (10 cm) in the descending aorta,
whereas the Vicorder measurements go from the carotid
to femoral artery. This can explain why the Vicorder
measurements are on average 1.6 m/s greater than the
MRI as the peripheral arteries are stiffer than the aorta
[14, 15]. The measurement of length with MRI is accur-
ate, though with the Vicorder an anatomical external
surface measure along the length of the major blood ves-
sels is used, which is a potential source of error. Despite
these differences it is reassuring that both are closely
and similarly related to age.
Comparisons with other studies
Vicorder pulse wave velocity has been assessed compre-
hensively in healthy subjects by Müller and colleagues
[16]. In comparison with the present study, they ob-
tained mean values of pulse wave velocity for 20–29 year
olds of 5.8 ± 0.7 m/s and for 40–49 years of 7.1 ± 0.9 m/s
which is slightly lower than our data particularly at the
younger age (6.7 ± 0.9 and 7.5 ± 1.2 m/s respectively,
Table 2). A likely explanation for this difference is in the
measurement of the carotid-femoral length. Müller et al.
have used the length from the suprasternal notch to the
top of the femoral cuff, whereas we have taken the
measurement to the middle of the cuff. Thus, our longer
length will record higher pulse wave velocities. We have
done this as the centre of the cuff has been shown to be
where the pressure measurement is actually recorded
[10]. Rogers et al [7] have looked at phase contrast MRI
to measure pulse wave velocity in different regions of
the aorta. Their values obtained from the proximal
Table 3 Vicorder haemodynamic data
Age groups (years):
20–29 30–39 40–49 50–59 60–69 70–79
Heart Rate 64 ± 14 63 ± 14 61 ± 7 64 ± 9 59 ± 9 69 ± 14
Systolic Pressure 121 ± 11 128 ± 11 123 ± 8 124 ± 8 123 ± 12 136 ± 11
Diastolic Pressure 65 ± 7 73 ± 7 67 ± 6 68 ± 10 67 ± 9 73 ± 6
Mean Pressure 88 ± 9 95 ± 9 90 ± 7 93 ± 8 91 ± 10 100 ± 8
Pulse Pressure 60 ± 6 55 ± 5 56 ± 5 56 ± 8 55 ± 6 64 ± 9
Ao Systolic Pressure 115 ± 10 121 ± 9 120 ± 7 122 ± 8 120 ± 12 134 ± 12
Ao Pulse Pressure 50 ± 5 49 ± 5 53 ± 4 53 ± 8 53 ± 6 61 ± 9
Augmentation 6.9 ± 3.5 7.0 ± 4.3 11.2 ± 3.6 11.9 ± 3.9 13.4 ± 3.8 16.5 ± 4.4
Augmentation Index 13.7 ± 6.9 13.9 ± 8.0 21.4 ± 6.3 21.9 ± 5.0 25.5 ± 6.6 27.0 ± 6.4
Heart rate (beats per minute), all other pressures measured in mmHg, and augmentation index is a percentage
Ao aortic
Table 4 Univariate correlations
Vicorder PWV P = MRI PWV P =
Height −0.042 0.363 −0.054 0.325
Weight 0.053 0.328 −0.044 0.354
Heart Rate 0.253 0.015 −0.213 0.035
Systolic Pressure 0.392 0.000 0.162 0.085
Diastolic Pressure 0.284 0.007 0.026 0.414
Mean Arterial Pressure 0.371 0.001 0.098 0.204
Pulse Pressure 0.286 0.007 0.224 0.028
Aortic Systolic Pressure 0.466 0.000 0.251 0.016
Aortic Pulse Pressure 0.389 0.000 0.347 0.001
Augmentation 0.358 0.001 0.419 0.000
Augmentation Index 0.290 0.006 0.377 0.000
Fig. 3 Relationship of Vicorder to phase contrast MRI (a) (y = 0.345x
+ 3.45, R2 = 0.073, R = 0.271 P < 0.05), and Bland Altman plot of the
two techniques (b). On average Vicorder values are 1.6 m/s greater
than MRI values. PWV: pulse wave velocity, and SD: standard deviation
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descending aorta which is a similar area as used in our
study are comparable to our study, though values par-
ticularly in the older age groups are lower. However, this
study was in a smaller cohort of patients and significant
variability is seen in the older subjects. For instance, in
the 20–29 year old Rogers et al. obtained a pulse wave
velocity of approximately 5 m/s (compared to 4.5 ±
1.5 m/s in the present study), and for 60–69 years old
approximately 9 m/s compared to 6.8 ± 2.1 m/s in the
present study. In a larger study of 162 normal subjects
Hickson and colleagues [17] have compared the Sphyg-
maCor and Vicorder devices and phase contrast MRI.
Their values of phase contrast MRI pulse wave velocity
in the descending thoracic aorta are very similar to the
current study. They did however show a closer relation-
ship of Vicorder pulse wave velocity measurements to
phase contrast MRI measurements than in the current
study (r = 0.64 vs r = 0.27 in current study). This higher
level of correlation may be due to the larger number of
subjects studied and the measurement of pulse wave vel-
ocity along the whole length of the descending aorta by
phase contrast MRI. Nevertheless Bland Altman plots
show a similar pattern to the current study with higher
overall mean values for Vicorder, and individual points
outside two standard deviations particularly at higher
levels of pulse wave velocity. Thus, the values of both
Vicorder and MRI pulse wave velocity obtained in this
study match very closely to published data.
Clinical significance
There are two issues of particular clinical significance
with these data. Firstly, measurement of pulse wave vel-
ocity is recommended in the 2013 European Society of
Cardiology/European Society of Hypertension guide-
lines for assessment of cardiovascular risk [18], though
there are continuing issues regarding clinical applica-
tion that have been recently highlighted [19]. The issue
that is most relevant to this study is that there are a
myriad of devices that can measure pulse wave velocity
and that these are not necessarily interchangeable. In
that regard, our data is very important comparing these
two techniques. In particular, as MR imaging becomes
more widely adapted in clinical cardiovascular diagnos-
tics, how this performs compared to other techniques
is very important. The second issue of clinical signifi-
cance is that with both techniques there were approxi-
mately 10 % of cases in which data was not obtainable
or usable. This was more prevalent in older subjects.
One of the advantages with the Vicorder system is that
it is easy to use, and so in this study all examinations
were performed by research nursing staff. However,
despite this there are cases where the carotid waveform
is simply not clear enough to identify the upstroke and
therefore not usable, and this appears higher than pre-
viously reported [11]. For the MRI scanning there were
similarly issues with both claustrophobia and tolerating
the scan, and also poor data quality which is predomin-
antly in the older subjects. The scans were performed
by experienced radiographers, though there were issues
with obtaining scans perpendicular to the descending
aorta in older subjects as a result of increased aortic
curvature. As these techniques move from a purely re-
search domain to clinical tools, these data are import-
ant to understand how these techniques perform. Our
data suggests that assessing pulse wave velocity in older
subjects requires careful attention to these technical is-
sues to avoid loss of potentially important data, and
more information is required to determine how other
techniques perform in these older subjects.
Limitations
These data are in normal subjects, so in subjects with
cardiovascular disease with increased vascular stiffness
the relationships described may be altered, and also
there may be additional issues with acquiring high qual-
ity data. Gender differences have been described with
measures of vascular stiffness [20], but this study was
not statistically powered to detect gender differences.
There are other methods to measure pulse wave velocity
with MRI. For instance, other areas of the aorta can be
assessed using phase contrast MRI. Hickson and col-
leagues [17] have shown that the abdominal aorta has
slightly higher rates of age-related increases in pulse
wave velocity relative to the descending thoracic aorta.
Other phase contrast techniques include determination
of flow-area [21], and cross-correlation methods [22]
(where flow is determined at several points along the de-
scending aorta). Ibrahim et al. [23] have shown that the
transit time (as used in this study) and cross-correlation
methods resulted in more reproducible measurements
compared to the flow-area method. Our MRI reproduci-
bility studies have more variation than the data pub-
lished by Ibrahim et al. explained by their much larger
study number. A dependency of heart rate on augmenta-
tion index has been reported for the SphygmoCor device
Table 5 Multivariate Linear Regression Analysis
Vicorder PWV as dependent variable: Beta SE P =
Age 0.603 0.009 0.000
Model R2 = 0.363, F = 40.5, ANOVA P < 0.0001
SE standard error
Table 6 Multivariate Linear Regression Analysis
MRI PWV as dependent variable Beta SE P =
Age 0.632 0.010 0.000
Heart Rate −0.256 0.014 0.006
Model R2 = 0.442, F = 27.7, ANOVA P < 0.0001
SE standard error
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[24]. As there is no published data on this issue with the
Vicorder device, we have not normalised data to heart
rate.
Conclusions
Both the Vicorder device and phase contrast MRI mea-
surements of pulse wave velocity are similarly and
strongly related to age. The decision on whether to use
one or the other in studies of vascular ageing will thus
be related to other factors – such as the portability and
ease of use of the Vicorder device, or need for additional
cardiovascular MR imaging.
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